Skip to main content
. 2020 Nov 21;12(11):1124. doi: 10.3390/pharmaceutics12111124

Figure 7.

Figure 7

Comparative plasma concentration–time profiles of optimized formulation and marketed formulation (mean ± SD, n = 3).